Tempus AI TEM is transitioning from a heavy-investment growth stage toward improved operating leverage and a more scalable mix of revenue. This is possible as the company integrates genomics, ...

Tempus AI is building a strong moat in healthcare AI with vast clinical/genomic datasets and robust infrastructure, driving high-growth potential. TEM achieved its first positive adjusted EBITDA in Q3 ...

The smart money has taken a liking to Tempus AI (TEM). Though the mid-cap is choppy, the growth profile and recent margin gains are hard to ignore as applied AI looks to pick up more traction. Tempus ...

TEM works by accelerating electrons, typically with energies between 80 and 300 kV, and directing them through a specimen thin enough for electron transmission. Because of their very short wavelength ...

The company, which specializes in artificial intelligence (AI) functionalities to aid drug discovery, could be a powerhouse, according to one market professional. The foundation of Mikson's argument ...

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Monday morning after the company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD ...

CANADA - 2025/04/23: In this photo illustration, the Tempus AI logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images) AstraZeneca ...

One of Cathie Wood's largest holdings, Tempus AI, was targeted by a short-seller. The report, released today, alleges Tempus is misleading investors about its use of artificial intelligence (AI), as ...

Tempus AI (NASDAQ: TEM), a healthcare technology company, posted impressive Q1 results with revenue reaching $255.7 million, up 75.4% year-over-year. Adjusted EBITDA improved significantly to $-16.2 ...

In the rapidly evolving field of structural biology, single particle analysis (SPA) and cryo-electron tomography (cryo-ET) are powerful techniques that allow scientists to better understand the ...

Tempus AI started off the year with a stellar rally, but then bounced back from its peak in early February. There's no way this stock will remain cheap for long. Tempus AI's financials have ...

We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands ...